Literature DB >> 21421048

Endothelin and hepatic wound healing.

Al-karim Khimji1, Don C Rockey.   

Abstract

Liver wound healing is a coordinated response to injury caused by infections (hepatitis) or toxins (alcohol) or other processes where activation of hepatic stellate cells are a central component. During stellate cell activation, a major phenotypic transformation occurs which leads to increased production of increased extracellular matrix proteins and smooth muscle α-actin the results is organ dysfunction due to gross architectural disruption and impaired blood flow. Endothelin-1 (ET-1) is produced in increased amounts and the cellular source of ET-1 shifts from endothelial cells to stellate cells during liver injury thus setting a feedback loop which accentuates further activation, stellate cell proliferation, and production of extracellular matrix proteins. Therapy directed at intervening the ET-1 signaling pathway has significant therapeutic potential in patients with liver disease. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421048      PMCID: PMC4129451          DOI: 10.1016/j.phrs.2011.03.005

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  124 in total

Review 1.  Endothelin receptor antagonists: current status and perspectives.

Authors:  M Clozel
Journal:  J Cardiovasc Pharmacol       Date:  2000       Impact factor: 3.105

2.  Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.

Authors:  I Alam; N M Bass; P Bacchetti; L Gee; D C Rockey
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

Review 3.  Connective tissue biology and hepatic fibrosis: report of a conference.

Authors:  D M Bissell; S L Friedman; J J Maher; F J Roll
Journal:  Hepatology       Date:  1990-03       Impact factor: 17.425

4.  Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence.

Authors:  M E Lee; K D Bloch; J A Clifford; T Quertermous
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

5.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.

Authors:  C Thirunavukkarasu; Y Yang; V M Subbotin; S A K Harvey; J Fung; C R Gandhi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 7.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

8.  Regulation of endothelin-1 gene expression by Fos and Jun.

Authors:  M E Lee; M S Dhadly; D H Temizer; J A Clifford; M Yoshizumi; T Quertermous
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

9.  Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid.

Authors:  Xuedong Chi; Kristin Anselmi; Simon Watkins; Chandrashekhar R Gandhi
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  14 in total

1.  Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes.

Authors:  Phil June Park; Tae Ryong Lee; Eun-Gyung Cho
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

Review 2.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

3.  Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.

Authors:  Zengdun Shi; Mudan Ren; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

Review 4.  Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Authors:  Natalie J Torok; Jonathan A Dranoff; Detlef Schuppan; Scott L Friedman
Journal:  Hepatology       Date:  2015-03-10       Impact factor: 17.425

5.  Smooth Muscle α-Actin Deficiency Leads to Decreased Liver Fibrosis via Impaired Cytoskeletal Signaling in Hepatic Stellate Cells.

Authors:  Don C Rockey; Qinghong Du; Zengdun Shi
Journal:  Am J Pathol       Date:  2019-08-30       Impact factor: 4.307

6.  Characterization of focal adhesion proteins in rodent hepatic stellate cells.

Authors:  Nour Hijazi; Zengdun Shi; Don C Rockey
Journal:  Histochem Cell Biol       Date:  2022-08-12       Impact factor: 2.531

Review 7.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

9.  Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injury.

Authors:  Arya J Bahrami; Jagadambika J Gunaje; Brian J Hayes; Kimberly J Riehle; Heidi L Kenerson; Raymond S Yeung; April S Stempien-Otero; Jean S Campbell; William M Mahoney
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  Influence of block of NF-kappa B signaling pathway on oxidative stress in the liver homogenates.

Authors:  Paulina Kleniewska; Aleksandra Piechota-Polanczyk; Lukasz Michalski; Marta Michalska; Ewa Balcerczak; Marta Zebrowska; Anna Goraca
Journal:  Oxid Med Cell Longev       Date:  2013-03-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.